Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, shares her views on the 3 most important recent advances in treating heart failure.
Are there still any unknown areas concerning target blood pressure (BP) values and therapeutic goals in older patients with hypertension?
What should be taken into consideration when choosing or switching antiplatelet agents in patients with coronary artery disease (CAD)?
Could you comment on noninvasive treatment options in patients with peripheral artery disease (PAD)?
Could you comment on invasive treatment options in patients with peripheral artery disease (PAD)?
Should aggressive medical treatment be used in every patient with peripheral artery disease (PAD), or should it be adjusted to disease severity?
Do you have any suggestions or recommendations on diagnostic workup of peripheral artery disease (PAD) performed by a general practitioner or another nonvascular specialist?
Is perioperative myocardial infarction (MI) an important issue? Do we have any methods for prevention and treatment?
Are elevated troponin levels a relevant finding in the intensive care unit (ICU)?
What is the recommended antiplatelet therapy in a patient with type 2 myocardial infarction (MI)?
English
Polski
Español
українська